XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE - Disaggregation (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Number of reportable segments | segment     2    
Revenue, net $ 61,492 $ 60,240 $ 190,969 $ 185,671  
Contract receivables, current 1,600   1,600   $ 1,500
Contract receivables, noncurrent 5,300   5,300   5,100
Current portion of deferred revenue, and other 7,700   7,700   $ 9,600
Contract liabilities, revenue recognized     7,900    
Contract liabilities, increase due to additional deferred sales     5,500    
Exchange rate impact     400    
VetZ GmbH          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Contact with customer, due to business acquisition     900    
North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 40,329 37,809 118,607 115,614  
International | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 21,163 22,431 72,362 70,057  
POC lab instruments & other | North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 3,630 3,547 11,821 10,017  
POC lab instruments & other | International | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 3,698 3,800 11,269 10,801  
POC lab consumables | North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 19,711 17,694 58,685 53,942  
POC lab consumables | International | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 9,381 11,223 31,621 35,383  
POC imaging & informatics | North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 7,688 7,433 19,641 21,222  
POC imaging & informatics | International | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 7,243 5,849 26,787 19,783  
PVD | North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 5,343 4,297 16,758 17,370  
PVD | International | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net 841 1,559 2,685 4,090  
OVP | North America | Operating Segments          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Revenue, net $ 3,957 $ 4,838 $ 11,702 $ 13,063